Related Experiment Videos
Leukocyte-induced endothelial dysfunction in the rabbit basilar artery: modulation by platelet-activating factor
S E Akopov1, R Sercombe, J Seylaz
1Laboratoire de Recherches Cérébrovasculaires, CNRS UA 641, Université Paris VII, France.
Journal of Lipid Mediators and Cell Signalling
|May 1, 1995
Summary
Activated polymorphonuclear leukocytes (PMNLs) impair blood vessel relaxation. Platelet-activating factor (PAF) enhances PMNL activation, leading to greater endothelial dysfunction and microlesions in the basilar artery.
Area of Science:
- Vascular biology
- Immunology
- Endothelial function
Background:
- Polymorphonuclear leukocytes (PMNLs) play a role in vascular inflammation.
- Endothelial dysfunction is a key factor in cardiovascular diseases.
- N-formyl-methionyl-leucyl-phenylalanine (fMLP) is a potent activator of PMNLs.
Purpose of the Study:
- To investigate the impact of activated PMNLs on endothelium-dependent relaxation of the rabbit basilar artery (BA).
- To determine the role of platelet-activating factor (PAF) in modulating PMNL-induced endothelial dysfunction.
Main Methods:
- Isolated rabbit basilar artery (BA) segments were used in organ bath studies.
- Endothelium-dependent relaxation was assessed using acetylcholine (ACh) and bradykinin.
- Endothelium-independent relaxation was measured with nitroprusside.
- PMNL activation was induced by fMLP, with or without PAF.
- Beta-glucuronidase activity was measured to assess PMNL exocytosis.
- Scanning electron microscopy (SEM) was used to examine endothelial morphology.
Main Results:
- Activated PMNLs significantly reduced endothelium-dependent relaxation to ACh and bradykinin (p < 0.05).
- PMNLs did not affect endothelium-independent relaxation to nitroprusside.
- Low concentrations of PAF potentiated PMNL-induced inhibition of relaxation.
- PAF enhanced PMNL exocytosis and caused more apparent endothelial microlesions.
- PAF enabled PMNLs to induce dysfunction at lower cell concentrations and shorter contact times.
Conclusions:
- Activated PMNLs significantly impair endothelium-dependent vasodilation.
- Platelet-activating factor (PAF) acts as a potentiator, increasing PMNL aggression towards the endothelium.
- PAF-mediated potentiation of PMNLs leads to exacerbated endothelial dysfunction and morphological damage.